新辅助化疗对乳腺癌细胞凋亡和增殖的影响

    Influence of neoadjuvant chemotherapy on apoptosis and proliferation in patients with breast caner

    • 摘要: 目的: 探讨新辅助化疗对乳腺癌肿瘤细胞的凋亡和增殖的影响。方法: 应用末端脱氧核苷酸转移酶介导dUTP缺口末端标记法(TdT-mediated dUTP-biotin nick end labeling,TUNEL)及免疫组化的S-P法,分别检测新辅助化疗组和对照组乳腺癌组织中肿瘤细胞的凋亡指数(AI)和乳腺癌肿瘤组织的Ki-67抗原表达。结果: 新辅助化疗组肿瘤细胞AI均数为9.26%,比对照组肿瘤细胞AI均数3.36%明显增高(P<0.01)。新辅助化疗组肿瘤细胞Ki-67抗原过表达率为15.63%,比对照组Ki-67抗原过表达率50.0%低(P<0.05)。结论: 新辅助化疗能诱导人体乳腺癌肿瘤细胞发生凋亡,并能抑制其增殖。

       

      Abstract: Objective: To study the influence of neoadjuvant chemotherapy on tumor cell apoptosis and proliferation in patients with breast cancer.Methods: The apoptosis index(AI) of tumor cells in the neoadjuvant group and control group was assayed by TdT-mediated dUTP-biotin nick end labeling(TUNEL),and the Ki-67 antigen was examined by immunohistochemical method.Results: The AI of tumor cells was 9.26 in the neoadjuvant group and 3.36 in the control group.The difference was significant(P<0.01).The overexpression rate of Ki-67 antigen in the neoadjuvant group was 15.63,which was 50.0 lower than that in the control group(P<0.05). Conclusions: Neoadjuvant chemotherapy can induce tumor cell apoptosis and inhibit tumor cell proliferation in patients with breast cancer.

       

    /

    返回文章
    返回